More than seven million people in England, Scotland and Wales are recorded as receiving support through the DWP's Universal ...
Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...